Yocabet, M. v. UPMC , 119 A.3d 1012 ( 2015 )


Menu:
  • J-A04009-15
    J-A04010-15
    
    2015 PA Super 132
    MICHAEL J. YOCABET,                         IN THE SUPERIOR COURT OF
    PENNSYLVANIA
    Appellee
    v.
    UPMC PRESBYTERIAN AND UNIVERSITY
    OF PITTSBURGH PHYSICIANS,
    APPEAL OF: UPMC PRESBYTERIAN
    SHADYSIDE,
    Appellant
    CHRISTINA L. MECANNIC,
    Appellee
    v.
    UPMC PRESBYTERIAN AND UNIVERSITY
    OF PITTSBURGH PHYSICIANS,
    APPEAL OF: UPMC PRESBYTERIAN
    SHADYSIDE,
    Appellant           No. 569 WDA 2014
    Appeal from the Order March 11, 2014
    In the Court of Common Pleas of Allegheny County
    Civil Division at No(s): G.D. NO. 11-19112, G.D. NO. 11-19113
    MICHAEL J. YOCABET,                         IN THE SUPERIOR COURT OF
    PENNSYLVANIA
    Appellee
    v.
    J-A04009-15
    J-A04010-15
    UPMC PRESBYTERIAN AND UNIVERSITY
    OF PITTSBURGH PHYSICIANS,
    APPEAL OF: UPMC PRESBYTERIAN
    SHADYSIDE,
    Appellant
    CHRISTINA L. MECANNIC,
    Appellee
    v.
    UPMC PRESBYTERIAN AND UNIVERSITY
    OF PITTSBURGH PHYSICIANS,
    APPEAL OF: UPMC PRESBYTERIAN
    SHADYSIDE,
    Appellant         No. 1230 WDA 2014
    Appeal from the Order June 26, 2014
    In the Court of Common Pleas of Allegheny County
    Civil Division at No(s): G.D. NO. 11-19112, G.D. NO. 11-19113
    BEFORE: BOWES, OLSON, and STRASSBURGER,* JJ.
    OPINION BY BOWES, J.:                                       FILED JUNE 5, 2015
    ____________________________________________
    *
    Retired Senior Judge assigned to the Superior Court.
    -2-
    J-A04009-15
    J-A04010-15
    UPMC Presbyterian Shadyside (“UPMC”) has filed these two appeals
    from pretrial discovery orders. Since the orders involve common issues of
    fact and law, we have consolidated them for disposition.          UPMC maintains
    that both orders, one dated March 11, 2014, and the other one dated June
    26, 2014, require it to produce materials that are confidential under the Peer
    Review Protection Act, 63 P.S. §§ 425.1-425.4 (the “Peer Review Act” or
    “Act”). We will generally refer to this privilege as the peer review privilege.
    UPMC also invokes the attorney-client privilege as to the materials ruled
    discoverable in the June 26, 2014 order.1            We affirm the March 11, 2014
    ____________________________________________
    1
    We conclude that we have jurisdiction herein, even though the orders in
    question are non-final. When a party is ordered to produce materials
    purportedly subject to a privilege, we have jurisdiction under Pa.R.A.P. 313,
    which outlines the collateral order doctrine. Pa.R.A.P. 313(b) (“A collateral
    order is an order separable from and collateral to the main cause of action
    where the right involved is too important to be denied review and the
    question presented is such that if review is postponed until final judgment in
    the case, the claim will be irreparably lost.”); see Dodson v. DeLeo, 
    872 A.2d 1237
     (Pa.Super. 2005) (where trial court ordered party to produce
    materials allegedly protected by the Peer Review Protection Act, order was
    collateral order); Law Office of Douglas T. Harris, Esquire v.
    Philadelphia Waterfront Partners, LP, 
    957 A.2d 1223
     (Pa.Super. 2008)
    (Pursuant to Pa.R.A.P. 313, where appealing party makes colorable claim
    that attorney-client privilege applies, we will review merits of order requiring
    disclosure). In Ben v. Schwartz, 
    729 A.2d 547
     (Pa. 1999), our Supreme
    Court ruled that orders refusing to apply a claimed privilege were
    immediately appealable as collateral orders. In Commonwealth v. Harris,
    
    32 A.3d 243
    , 252 (Pa. 2011), our Supreme Court re-affirmed that “orders
    overruling claims of privilege and requiring disclosure are immediately
    appealable under Pa.R.A.P. 313” despite the United States Supreme Court’s
    decision in Mohawk Industries, Inc. v. Carpenter, 
    558 U.S. 100
     (2009),
    (Footnote Continued Next Page)
    -3-
    J-A04009-15
    J-A04010-15
    order. We reverse the June 26, 2014 order and remand for the conduct of in
    camera review in order to determine whether either privilege invoked by
    UPMC applies to the materials involved therein.
    These appeals stem from two civil cases involving allegations of, inter
    alia, medical malpractice.                  At lower court docket number GD 11-19112,
    Michael J. Yocabet instituted a lawsuit against UPMC and University of
    Pittsburgh Physicians, and at lower court docket number GD 11-19113,
    Christina L. Mecannic filed a civil action against the same entities. The two
    lawsuits pertain to the same event, a kidney transplant. We summarize the
    allegations contained in the complaints.                Mr. Yocabet was on the kidney
    transplant waiting list at UPMC awaiting a new kidney due to damage to that
    organ caused by his Type I diabetes.                    Ms. Mecannic was Mr. Yocabet’s
    significant other and the mother of his son.                Ms. Mecannic volunteered to
    undergo the necessary testing to determine if her eligibility to be a kidney
    donor for Mr. Yocabet.
    Mr. Yocabet did not have Hepatitis C prior to the kidney transplant
    surgery.        On January 26, 2011, Ms. Mecannic underwent blood test
    _______________________
    (Footnote Continued)
    which disallows such appeals in the federal system. See also
    Commonwealth v. Williams, 
    86 A.3d 771
     (Pa. 2014) (reviewing propriety
    of order from PCRA court compelling Commonwealth to produce materials
    that it contended were protected under work product doctrine); In re
    Thirty-Third Statewide Investigating Grand Jury, 
    86 A.3d 204
    , 215 (Pa.
    2014) (reviewing orders that purportedly violated attorney-client privilege
    and other statutory privileges).
    -4-
    J-A04009-15
    J-A04010-15
    screening, and that testing revealed that she had Hepatitis C.       Having
    Hepatitis C renders a person ineligible to be a kidney donor under federal
    guidelines and UPMC policies.    Follow-up testing was recommended, but
    none was ordered.
    On January 26, 2011, Dr. Mark Sturdevant, a UPMC transplant
    surgeon, documented that he reviewed Ms. Meccanic’s laboratory work,
    which would have included the positive results for Hepatitis C.          He
    recommended her as an excellent kidney donor candidate. That same day,
    UPMC nephrologist Dr. Nirav Shah documented that he reviewed Ms.
    Meccanic’s laboratory work. Dr. Shah indicated that she appeared to be a
    reasonable donor candidate.     On January 31, 2011, UPMC physician Dr.
    Jennifer L. Steel reviewed Ms. Meccanic’s records, which would have
    included the positive results for Hepatitis C.    Dr. Steel approved Ms.
    Meccanic as a donor and found no contraindications for donation.
    UPMC Transplant Selection Committee meetings were held on February
    17, 2011, and March 23, 2011. Ms. Meccanic’s qualifications and test results
    were discussed at those meetings, where she was approved as a donor. If
    anyone during these five review processes had noticed Ms. Meccanic’s
    positive test for Hepatitis C, she would not have been approved as a kidney
    donor for Mr. Yocabet.   In a March 24, 2011 letter to Ms. Meccanic, Mimi
    Funovitis, a nurse and UPMC’s transplant coordinator, informed Ms. Meccanic
    -5-
    J-A04009-15
    J-A04010-15
    that, after a review of Ms. Meccnic’s evaluation test results and interviews,
    Ms. Meccanic was medically approved to be a kidney donor.
    On March 29, 2011, Ms. Mecannic underwent additional blood testing
    ordered by Dr. Henkie Tan.      That testing also included a screening for
    Hepatitis C, and the results indicated that there was an insufficient quantity
    of blood to perform the ordered testing.    Those results were faxed to Ms.
    Funovitis. Ms. Funovitis documented that Ms. Mecannic’s blood had to be re-
    drawn, but UPMC did not secure more blood from Ms. Meccanic. On April 1,
    2011, Dr. Tan, the lead surgeon on the transplant team, completed a form
    known as a transplant surgery consultation, wherein he noted Ms. Mecannic
    was a suitable candidate for donation.
    One of Ms. Mecannic’s kidneys was transplanted into Mr. Yocabet on
    April 6, 2011.   At some unknown time after the surgery, UPMC personnel
    discovered that they had transplanted a Hepatitis C infected kidney into Mr.
    Yocabet. On April 22, 2011, UPMC obtained another blood sample from Ms.
    Meccanic without telling her the blood analysis was being performed solely
    to determine her level of Hepatitis C infection and was not standard donor
    testing following transplant surgery.    On May 6, 2011, UPMC personnel
    informed Ms. Meccanic that she had Hepatitis C.
    Mr. Yocabet subsequently contracted Hepatitis C from Ms. Mecannic’s
    donated kidney. An infectious disease doctor informed Mr. Yocabet that the
    -6-
    J-A04009-15
    J-A04010-15
    Hepatitis C treatment would eventually result in kidney failure and death.
    Ms. Meccanic underwent surgery that should not have been performed and
    was left with one kidney.
    After the complaints were filed, these two actions were consolidated at
    GD 11-019112 for purposes of discovery.                 The plaintiffs submitted
    interrogatories and a request for production of documents and then a motion
    to compel. Due to the complexity of the discovery issues, the matter was
    referred to a special master, Roslyn M. Litman, Esquire.
    The following facts are pertinent to the issues involved in these
    appeals.     After   the   transplant   at   issue   occurred,   the   Pennsylvania
    Department of Health (“Department of Health”), on behalf of the Centers for
    Medicare and Medicaid Services, conducted an investigation of the UPMC
    transplant program (“CMS/DOH investigation”).           The Centers for Medicare
    and Medicaid Services is a federal agency within the United States
    Department of Health and Human Services. It administers the Medicare and
    Medicaid insurance programs and collaborates with state governments to
    administer Medicaid, a social services program that provides health
    insurance for individuals and families with low income and limited financial
    resources.    During discovery, the plaintiffs sought the communications,
    which consisted of documents and interviews, submitted by UPMC to the
    Department of Health for purposes of the CMS/DOH investigations.             UPMC
    -7-
    J-A04009-15
    J-A04010-15
    claimed that the requested materials were confidential under the Peer
    Review Act.
    The master opined that the documents and interviews submitted to
    the Department of Health were not confidential since it was not conducting
    peer review during the CMS/DOH investigation. UPMC filed objections to the
    master’s conclusion that the plaintiffs could obtain the documents and
    interviews reviewed for purposes of the CMS/DOH investigation. In a March
    11, 2014 order, the trial court affirmed the master’s conclusion that the peer
    review privilege did not apply to the materials submitted by UPMC to the
    Department of Health during the CMS/DOH investigation. The appeal at 569
    WDA 2014 followed. The issue raised therein is: “Whether documents and
    communications generated as a result of the CMS/DOH investigation of the
    medical treatment at issue are protected from discovery by the Pennsylvania
    Peer Review Protection Act (63 P.S. § 425.1 et seq.)?” Appellant’s brief (569
    WDA 2014) at 5.
    The June 26, 2014 order on appeal at 1230 WDA 2014 concerns the
    following facts. The plaintiffs requested information about a May 11, 2011
    meeting of the Board of Directors of UPMC (“May 11, 2011 Board meeting”).
    UPMC objected to that request and claimed that the information sought was
    shielded from discovery by both the Peer Review Act and the attorney-client
    privilege.   The master recommended that the attorney-client privilege be
    -8-
    J-A04009-15
    J-A04010-15
    held applicable; concomitantly, she did not reach the peer review issue. The
    plaintiffs objected to this recommendation as well as a number of the
    master’s other discovery conclusions.
    On June 26, 2014, the plaintiffs’ objections were granted in part, and
    the trial court, without reviewing the board minutes to determine whether a
    privilege applied, ordered UPMC to produce the information that the plaintiffs
    had requested about the May 11, 2011 Board meeting.           The trial court
    concluded that the attorney-client privilege was inapplicable; it did not
    address whether the confidentiality provision outlined in the Peer Review Act
    applied. The appeal at 1230 WDA 2014 followed. The issues raised therein
    are:
    A. Whether the trial court erred in ruling that documents and
    other information regarding a board meeting following the
    incident at issue are not protected from discovery by the
    attorney-client privilege?
    B. Whether the trial court erred in ruling that documents and
    other information regarding a board meeting following the
    incident at issue are not protected from discovery by the peer
    review privilege?
    Appellant’s brief (1230 WDA 2014) at 5.
    I.    Standard and Scope of Review and
    Burden of proof
    In these appeals, we are called upon to determine whether the Peer
    Review Act’s confidentiality provision protects from discovery the materials
    sought with respect to the CMS/DOH investigation and the May 11, 2011
    -9-
    J-A04009-15
    J-A04010-15
    Board meeting.     We thus engage in an interpretation of its provisions.
    Where “the issue is the proper interpretation of a statute, it poses a question
    of law; thus, our standard of review is de novo, and the scope of our review
    is plenary.” Phoenixville Hosp. v. Workers' Compensation Appeal Bd.
    (Shoap), 
    81 A.3d 830
    , 838 (Pa. 2013); accord In re Thirty-Third
    Statewide Investigating Grand Jury, 
    86 A.3d 204
    , 215 (Pa. 2014) (if an
    appellant invokes a statutory privilege, appellate review is plenary).     We
    must review the applicability of the attorney-client privilege with regard to
    the May 11, 2011 Board meeting. “Whether the attorney-client privilege or
    the work product doctrine protects a communication from disclosure is a
    question of law.” In re Thirty-Third Statewide Investigating Grand
    Jury, supra at 215. Thus, the same standards apply with respect to both
    privileges.
    The “party invoking a privilege must initially set forth facts showing
    that the privilege has been properly invoked[.]” Red Vision Systems, Inc.
    v. National Real Estate Information Services, L.P., 
    108 A.3d 54
    ,
    62 (Pa.Super. 2015) (attorney-client privilege); accord In re T.B., 
    75 A.3d 485
     (Pa.Super. 2013) (statutory privilege applicable to communications to
    psychiatrist and psychologists).    Once the invoking party has made the
    appropriate proffer, then the burden shifts to the party seeking disclosure to
    set forth facts showing that disclosure should be compelled either because
    - 10 -
    J-A04009-15
    J-A04010-15
    the privilege has been waived or because an exception to the privilege
    applies. Red Vision Systems, Inc., 
    supra;
     In re T.B., 
    supra.
    While there are no exceptions to the peer review privilege articulated
    in the case law thus far, in the attorney-client context, there are a number.
    The attorney-client privilege will not be upheld when the client has attacked
    the honesty or professionalism of the attorney, when the advice was sought
    for the purpose of committing a crime, and where nondisclosure would have
    the sole effect of frustrating the administration of justice.       Red Vision
    Systems, Inc., supra. Additionally, “if the private good of protection from
    the harm that could come with disclosure of attorney-client communications
    is not furthered by application of the privilege, it is inapplicable.” Id. at 62.
    Thus, for purposes of these appeals, we must examine whether UPMC, as
    the party with the initial burden of proof, has presented sufficient facts to
    bring the asserted privilege into play.
    II.  Appeal 569 WDA 2004
    CMS/DOH Investigation: Peer Review Privilege
    In this appeal, the claimed privilege is the one outlined in the Peer
    Review Act.    Our primary focus in determining whether the peer review
    privilege applies is “directed to the plain language of the provisions” of the
    statute in question. In re Thirty-Third Statewide Investigating Grand
    Jury, supra at 215.
    - 11 -
    J-A04009-15
    J-A04010-15
    We have observed that the purpose of the Peer Review Act’s
    confidentiality provision is to “to facilitate self-policing in the health care
    industry.”     Dodson v. DeLeo, 
    872 A.2d 1237
    , 1242 (Pa.Super. 2005).
    Since the Peer Review Act embodies the legislature’s belief that the “medical
    profession itself is in the best position to police its own activities,” the Peer
    Review   Act    is   designed   to   encourage   “comprehensive,   honest,   and
    potentially critical evaluations of medical professionals by their peers.” 
    Id.
    As we more specifically delineated in Sanderson v. Frank S. Bryan, M.D.,
    Ltd., 
    522 A.2d 1138
    , 1139 (Pa.Super. 1987):
    The medical profession exercises self-regulation. The most
    common form of such regulation in the health care industry is the
    peer review organization. Hospital peer review organizations are
    usually composed of physicians who review and evaluate other
    physicians' credentials and medical practices. Generally, hospital
    peer review findings and records are protected from public
    scrutiny either legislatively, or by court decision. The purpose for
    such protection is to encourage increased peer review activity
    which will result, it is hoped, in improved health care.
    The report issued after the CMS/DOH investigation is publicly
    available. A review of the report reveals that the purpose of the CMS/DOH
    investigation was to determine if UPMC’s kidney transplant program was in
    compliance with the requirements of the Centers for Medicare and Medicaid
    Services and thus eligible to continue to participate in the Medicare/Medicaid
    program. Exhibit 4, Master’s Report and Recommendations Re Discovery
    Disputes Resulting from Plaintiff[s’] Motion to Compel, 10/22/13.            The
    - 12 -
    J-A04009-15
    J-A04010-15
    Department of Health stated in its report that it conducted an “unannounced
    Medicare complaint survey” at UPMC on June 7 and June 8, 2011. Id. at 1.
    The Department of Health personnel met with the hospital’s administrators
    and transplant program staff.
    The report noted that a transplant center located within a hospital that
    has   a   Medicare   provider   agreement     must   meet   “the   conditions   of
    participation specified in § 482.72 through § 482.104 in order to be granted
    approval from [the Centers for Medicare and Medicaid Services] to provide
    transplant services.”   Id. at 2.   The report continued that, in addition to
    meeting those conditions, “a transplant center must also meet the conditions
    of participation specified in § 482.1 through § 482.57.” Id.
    The report stated, “Based on review of facility documents and
    interview with staff,” the Department of Health concluded that the “Adult
    Kidney Only (AKO) program [at UPMC] failed to ensure that the facility met
    the conditions of participation specified in § 482.90 Patient and Living Donor
    Selection.” Id. After finding multiple violations of § 482.90, the Department
    of Health outlined an eleven-page           plan of correction and assigned
    responsibility for implementation of different aspects of the plan to different
    staff members employed by UPMC. The plan of correction was designed to
    bring UPMC into compliance with the conditions of participation specified in
    - 13 -
    J-A04009-15
    J-A04010-15
    the § 482.90 so that it could continue to receive payments under Medicare
    and Medicaid.
    Hence, the report establishes that the purpose of the CMS/DOH
    investigation was to determine whether UPMC had complied with conditions
    and requirements to operate as a transplant center under applicable federal
    guidelines and whether its adult kidney transplant program could continue to
    participate in the Medicare and Medicaid programs.
    We conclude the confidentiality provision of the Peer Review Act does
    not apply to the CMS/DOH investigation because the Department of Health is
    not a professional health care provider and thus did not conduct peer review.
    The peer review privilege provides that the “proceedings and records of a
    review committee shall be held in confidence[.]” 63 P.S. § 425.4.2 A review
    ____________________________________________
    2
    The complete statutory text is as follows:
    The proceedings and records of a review committee shall be
    held in confidence and shall not be subject to discovery or
    introduction into evidence in any civil action against a
    professional health care provider arising out of the matters which
    are the subject of evaluation and review by such committee and
    no person who was in attendance at a meeting of such
    committee shall be permitted or required to testify in any such
    civil action as to any evidence or other matters produced or
    presented during the proceedings of such committee or as to any
    findings, recommendations, evaluations, opinions or other
    actions of such committee or any members thereof: Provided,
    however, that information, documents or records otherwise
    available from original sources are not to be construed as
    immune from discovery or use in any such civil action merely
    (Footnote Continued Next Page)
    - 14 -
    J-A04009-15
    J-A04010-15
    organization is identified in the Act as “any committee engaging in peer
    review[.]”      63 P.S. § 425.2.3                Peer review is defined as “a procedure for
    evaluation by professional health care providers” of the quality and
    _______________________
    (Footnote Continued)
    because they were presented during proceedings of such
    committee, nor should any person who testifies before such
    committee or who is a member of such committee be prevented
    from testifying as to matters within his knowledge, but the said
    witness cannot be asked about his testimony before such a
    committee or opinions formed by him as a result of said
    committee hearings.
    63 P.S. § 425.4.
    3
    The full definition of “review organization” is
    any committee engaging in peer review, including a hospital
    utilization review committee, a hospital tissue committee, a
    health insurance review committee, a hospital plan corporation
    review committee, a professional health service plan review
    committee, a dental review committee, a physicians' advisory
    committee, a veterinary review committee, a nursing advisory
    committee, any committee established pursuant to the medical
    assistance program, and any committee established by one or
    more State or local professional societies, to gather and review
    information relating to the care and treatment of patients for the
    purposes of (i) evaluating and improving the quality of health
    care rendered; (ii) reducing morbidity or mortality; or (iii)
    establishing and enforcing guidelines designed to keep within
    reasonable bounds the cost of health care. It shall also mean
    any hospital board, committee or individual reviewing the
    professional qualifications or activities of its medical staff or
    applicants for admission thereto. It shall also mean a committee
    of an association of professional health care providers reviewing
    the operation of hospitals, nursing homes, convalescent homes
    or other health care facilities.
    63 P.S. § 425.2.
    - 15 -
    J-A04009-15
    J-A04010-15
    efficiency of services ordered or performed by other “professional health
    care providers.”            63 P.S. § 425.2 (emphasis added).4   Thus, peer review
    occurs only when one professional health care provider is evaluating another
    professional health care provider.
    UPMC is a professional health care provider, as defined by the Peer
    Review Act, but neither the Pennsylvania Department of Health nor the
    Centers for Medicare and Medicaid Services is a professional health care
    provider. Since the Department of Health and the Centers for Medicare and
    Medicaid Services are not professional health care providers, the Department
    of Health did not engage in peer review during the CMS/DOH investigation.
    ____________________________________________
    4
    In full, “peer review”
    means the procedure for evaluation by professional health care
    providers of the quality and efficiency of services ordered or
    performed by other professional health care providers, including
    practice analysis, inpatient hospital and extended care facility
    utilization review, medical audit, ambulatory care review, claims
    review, and the compliance of a hospital, nursing home or
    convalescent home or other health care facility operated by a
    professional health care provider with the standards set by an
    association of health care providers and with applicable laws,
    rules and regulations. Peer review, as it applies to veterinarians,
    shall mean the procedure for evaluation by licensed doctors of
    veterinary medicine of the quality and efficiency of veterinary
    medicine ordered or performed by other doctors of veterinary
    medicine with the standards set by an association of doctors of
    veterinary medicine and with applicable laws, rules and
    regulations.
    63 P.S. § 425.2.
    - 16 -
    J-A04009-15
    J-A04010-15
    Thus, the records tendered by UPMC for purposes of the CMS/DOH
    investigation are not, by the clear and unequivocal terms of the Peer Review
    Act, subject to the peer review privilege. Our analysis follows.
    The Peer Review Act sets forth that a “professional health care
    provider”
    means individuals or organizations who are approved, licensed,
    or otherwise regulated to practice or operate in the health care
    field under the law of the Commonwealth, including, but not
    limited to, the following individuals or organizations:
    (1) A physician.
    (2) A dentist.
    (3) A podiatrist.
    (4) A chiropractor.
    (5) An optometrist.
    (6) A psychologist.
    (7) A pharmacist.
    (8) A registered or practical nurse.
    (9) A physical therapist.
    (10) An administrator of a hospital, a nursing or
    convalescent home, or other health care facility.
    (11) A corporation or other organization operating a
    hospital, a nursing or convalescent home or other
    health care facility.
    63 P.S. § 425.2.
    - 17 -
    J-A04009-15
    J-A04010-15
    The Department of Health and the Centers for Medicare and Medicaid
    Services are not organizations approved, licensed, or otherwise regulated to
    practice or operate in the health care field.    Neither the Department of
    Health nor the Centers for Medicare and Medicaid Services falls within any of
    the enumerated eleven categories defining a professional health care
    provider. Instead, the Department of Health is a state agency. Its “mission
    is to promote healthy lifestyles, prevent injury and disease, and to assure
    the safe delivery of quality health care for all Commonwealth citizens.”
    http://www.health.pa.gov. The Department of Health does not itself provide
    health care to people.
    McClellan v. Health Maintenance Organization, 
    660 A.2d 97
    (Pa.Super. 1995), aff’d by an equally divided court, 
    686 A.2d 801
     (Pa.
    1996), is dispositive.   In that case, the plaintiffs brought personal injury
    lawsuits against a doctor and a health maintenance organization (“HMO”)
    after the doctor failed to biopsy a malignant mole removed from plaintiffs’
    decedent. The HMO was alleged to have engaged in corporate negligence
    due to its failure to retain responsible doctors and to review its doctors to
    ensure that the doctors provided competent health care. After the plaintiffs
    filed a request for production of documents, the HMO claimed that those
    items were subject to the peer review privilege. The trial court compelled
    the HMO to produce the materials, and the HMO appealed. We concluded
    - 18 -
    J-A04009-15
    J-A04010-15
    that the privilege did not apply because the HMO in question was not a
    professional health care provider as defined in the Peer Review Act.
    We delineated the following in McClellan. The structure of any HMO,
    which provides both health insurance and health care, can widely vary, and
    the diverse models change the degree to which the HMO acts as a direct
    health care provider.    A staff-model HMO provides health care services
    through its own doctors and other health care professionals who are paid
    employees.    A staff-model HMO also owns or leases its own facilities, and
    operates and oversees the administration of primary care services. A group-
    model HMO involves contractual relationships between the HMO and
    physician groups.
    An independent practice association HMO “contracts for delivery of
    services with a partnership, corporation, or association whose major
    objective is to enter into contractual arrangements with health professionals
    for the delivery of such health services.”    Id. at 101 (citation omitted).
    Those physicians contracting with this model of HMO typically practice in
    their own office, own their own equipment and records, and are paid by the
    HMO a fee for services rendered. Those types of HMOs largely operate as
    providers of health insurance.
    The HMO at issue was an independent practice association HMO, and
    we concluded that the HMO was not a professional health care provider
    - 19 -
    J-A04009-15
    J-A04010-15
    because it did not practice or operate in the health care field and was not
    included within the eleven categories of people and organizations defined as
    professional health care providers in the Peer Review Act.                   We refused to
    read into the Peer Review Act’s definition of professional health care provider
    any “medical institutions or groups . . . that are not specifically identified by
    the legislature.”          Id. at 102.         Likewise, herein, the Department of Health
    does not provide health care.
    UPMC        attempts         to    convert   the   Department   of   Health   into    a
    professional health care provider by asserting that the Department of Health
    personnel involved in the investigation were doctors and nurses, who are
    defined as professional health care providers in the Peer Review Act.                        We
    hold that an entity that is not itself a professional health care provider does
    not become one merely because it hires a professional health care provider
    to conduct its investigation.
    The Department of Health is a fictitious entity that can only operate
    through its agents and employees.5 The qualifications of a person hired by
    the Department of Health does not alter either what it does or its purposes.
    We find Piroli v. Lodico, 
    909 A.2d 846
     (Pa.Super. 2006), instructive.
    Therein, a billing manager was present during a peer review proceeding
    conducted by a professional health care provider of a doctor credentialed at
    ____________________________________________
    5
    This legal precept is discussed in more detail in the text infra.
    - 20 -
    J-A04009-15
    J-A04010-15
    its facility. We concluded that the “mere fact that the billing manager was
    present, in addition to the health care professionals” on a committee
    conducting peer review under the Peer Review Act, did “not serve to
    eviscerate the protections that the legislature intended the [Peer Review
    Act] to provide.” 
    Id. at 852
    . We thus held that the peer review proceedings
    remained confidential despite the fact that review occurred in the presence
    of a person who was not a professional health care provider as defined in the
    Peer Review Act. Conversely, in this case, the Department of Health did not
    become a professional health care provider for purposes of the Peer Review
    Act by virtue of the fact that it hired doctors and nurses to conduct its
    investigation.
    Additionally, providing confidentiality herein would not advance the
    purpose of the Peer Review Act, which is designed “to facilitate self-policing
    in the health care industry.”   Dodson, supra at 1242.           This review was
    conducted by a state agency on behalf of a federal agency and did not, to
    any extent, involve self-policing by the health care industry.
    UPMC was not, by participating in the investigation, policing its own
    activities nor was any medical professional doing so.      Instead, UPMC was
    reporting to a governmental body so that it could retain the right to receive
    payment from programs covering a group of its patients. UPMC personnel
    were aware that their interviews were being conducted by a governmental
    - 21 -
    J-A04009-15
    J-A04010-15
    oversight organization and that UPMC’s status as an approved transplant
    center for purposes of Medicare/Medicaid was in jeopardy. Thus, application
    of the peer review privilege to the CMS/DOH investigation does not advance
    the impetus behind the Act’s enactment.
    UPMC insists, however, that there is another public policy reason for
    upholding the peer review privilege.   Appellant’s brief (569 WDA 2014) at
    27. Rather than examine the rationale behind the Peer Review Act, which is
    the law implicated herein, UPMC invokes the Right-To-Know Law. 65 P.S. §§
    67.701, et seq. UPMC suggests that “the Department of Health documents”
    would be exempt from public access under that statute. Id.
    The Right-to-Know Law is completely irrelevant in this matter.      The
    plaintiffs are not requesting anything from the Department of Health. As the
    plaintiffs aptly observe, they have “requested documents in UPMC’s
    possession, directly from UPMC in a lawsuit against UPMC.” Appellees’ brief
    (569 WDA 2014) at 18. This case does not involve a member of the public
    who is requesting items from the Department of Health pursuant to a statute
    granting public access to records in the possession of a “Commonwealth
    agency, a local agency, a judicial agency or a legislative agency.” 65 P.S. §
    67.701.
    The plaintiffs seek materials submitted to the Department of Health by
    UPMC for purposes of the CMS/DOH investigation rather than anything
    - 22 -
    J-A04009-15
    J-A04010-15
    generated by the Department of Health. UPMC has insisted that it does not
    have to reveal any materials that it tendered to the Department of Health
    because those items are protected by the peer review privilege.          The
    privilege is not validly invoked with respect to materials that UPMC tendered
    to the Department of Health because the Department of Health did not
    conduct peer review as defined in the Act.
    UPMC also points out that peer review can apply to investigations
    performed “by outside entities.”   Appellant’s brief (569 WDA 2014) at 14.
    We agree with this proposition. However, under the unequivocal language
    of the Peer Review Act, peer review can be initiated only by a professional
    health care provider.    An external committee formed or retained by a
    professional health care provider to conduct peer review and composed of
    professional health care providers outside its employ would qualify as a
    review organization.     However, the Department of Health is not a
    professional health care provider; consequently, any committee formed by it
    cannot be a review committee.
    In conclusion, a review committee must be “engaging in peer review,”
    and peer review is a “procedure for evaluation by professional health care
    providers” of services performed by other professional health care providers.
    63 P.S. § 425.2. The Pennsylvania Department of Health, acting on behalf
    of the Centers for Medicare and Medicaid Services, did not, during the
    - 23 -
    J-A04009-15
    J-A04010-15
    CMS/DOH investigation conduct peer review because it is not a professional
    health care provider.6              Hence, the documents and interviews submitted by
    UPMC for purposes of the CMS/DOH investigation are not protected by the
    peer review privilege.
    UPMC’s insistence that it does not have to provide any materials given
    to the Department of Health for purposes of the CMS/DOH investigation is
    flawed for a second reason.                    UPMC has invoked peer-review-privilege
    protection for any document or record that it submitted to the Department
    of Health during the CMS/DOH investigation.                   At oral argument, UPMC
    represented that even an incident report would be confidential if used in
    connection with a peer review process. This position is contrary to the terms
    of the confidentiality provision of the Peer Review Act and applicable law.
    The Peer Review Act provides in pertinent part that “proceedings and
    records of a review committee shall be held in confidence and shall not be
    subject to discovery.”               63 P.S. § 425.4.    It continues that “information,
    documents or records otherwise available from original sources are not to be
    ____________________________________________
    6
    In asserting that the peer review privilege applies herein, UPMC relies upon
    a three-paragraph decision in Bush v. Wright, 
    222 A.D.2d 546
    , 
    635 N.Y.S.2d 87
     (N.Y.A.D. 1995), wherein the Court held that the state
    department of health’s investigation of a hospital incident was confidential
    under a New York statute. UPMC, however, fails to analyze the New York
    statute involved therein and does not establish that it contains provisions
    analogous to those in the Act.
    - 24 -
    J-A04009-15
    J-A04010-15
    construed as immune from discovery or use in any such civil action merely
    because they were presented during proceedings of such committee[.]” 
    Id.
    In Dodson, 
    supra at 1242
    , we specifically held that the Peer Review
    Act does not “protect non-peer review business records, even if those
    records eventually are used by a peer review committee.” Thus, an incident
    report is not protected by the peer review privilege, even when such reports
    are reviewed by a peer review organization               Atkins v. Pottstown
    Memorial Med. Center, 
    634 A.2d 258
     (Pa.Super. 1993). As we observed
    in that case,
    After careful review of the purposes to be achieved by the
    statute, we conclude that the trial court erred when it excluded
    evidence of the incident report.      This document contained
    information “otherwise available from original sources.” It was
    not derived from nor part of an evaluation or review by a peer
    review committee. It was, rather, a report of an incident based
    on information also available to plaintiffs. As such, the report
    did not come within the need for confidentiality which the statute
    was intended to provide.
    
    Id. at 260
    .
    Accordingly, we reject UPMC’s assertion that a record or document
    automatically is covered by the peer review privilege merely because it was
    forwarded to a peer review committee.           The Department of Health report
    indicates that   its   findings were     premised upon facility    policies and
    documents, medical records, and staff interviews.         Since, in this appeal,
    UPMC does not assert that any of the materials that UPMC submitted to the
    - 25 -
    J-A04009-15
    J-A04010-15
    Department of Health were generated as a result of an internal peer review
    process, we affirm the trial court’s refusal to apply UPMC’s blanket assertion
    of confidentiality to the materials that UPMC gave to the Department of
    Health for purposes of the CMS/DOH investigation.          For the foregoing
    reasons, we find that UPMC has not properly invoked the peer review
    privilege, and we affirm the March 11, 2014 order.
    III. Appeal at 1230 WDA 2014:
    May 11, 2011 Board meeting
    This appeal concerns two interrogatories disseminated to UPMC by the
    plaintiffs wherein they sought the production of documents, communications
    and other information relating to the May 11, 2011 Board meeting, as
    follows:
    23. Regarding a UPMC board meeting on May 11, 2011,
    please: (a) produce any board minutes relating to this incident
    and/or any investigation of the transplant program in 2011; (b)
    identify and produce any documents provided to the board
    relating to this incident; (c) state whether it is admitted that
    Elizabeth Concordia mentioned that the test result for hepatitis C
    was missed by two people on the transplant team during a dozen
    steps in the process; (d) describe what Ms. Concordia told the
    board; and (e) identify the individuals present for the May 11,
    2011 board meeting.
    24. It is admitted that - during a board meeting on May
    11, 2011 – Elizabeth Concordia described this incident as a
    "systematic" problem in the way protocols failed? If so: (a)
    describe what Ms. Concordia was referring to as a systematic
    problem; (b) identify and produce the protocols that Ms.
    Concordia was referring to; and (c) identify the individuals
    and/or documents that Ms. Concordia got her information from
    regarding this incident prior to briefing the board.
    - 26 -
    J-A04009-15
    J-A04010-15
    Plaintiff’s First Set of Interrogatories and Request for Production of
    Documents       Directed    to   Defendant   UPMC    Presbyterian,   12/16/11,    at
    interrogatories ## 23-24.
    UPMC claimed the peer review privilege and the attorney-client
    privilege applied to all of the information sought in these requests.             In
    support of the peer review privilege, UPMC maintained the following.             The
    transplant program and the incident at issue were discussed at this meeting.
    The Board of Directors of UPMC also examined the activities of the transplant
    program and the specifics of the kidney transplant at issue herein, including
    the donor review process, and corrective actions to be taken in the
    transplant program.        Answers to Plaintiff's First Set of Interrogatories and
    Request   for    Production      of   Documents   Directed   to   Defendant   UPMC
    Presbyterian (Revised), 11/5/12, at answers ## 23-24.
    UPMC also invoked the attorney-client privilege based on its averment
    that one or more attorneys were present at the meeting so that the Board
    could obtain legal advice. UPMC continued that some communications at the
    May 11, 2011 Board meeting involved the kidney transplant program, the
    kidney donation herein, and were made for purposes of securing legal
    counsel from the attorney or attorneys. 
    Id.
    The master recommended acceptance of UPMC’s position that the
    attorney-client privilege applied to plaintiffs’ interrogatories 23 and 24. The
    - 27 -
    J-A04009-15
    J-A04010-15
    trial court disagreed. It noted that the record indicated that, at the May 11,
    2011 Board meeting, Elizabeth Concordia, UPMC’s Executive Vice-President,
    presented information to the Board about the incident and that there was no
    claim that she is a lawyer.       The trial court concluded that “nothing in the
    record . . . would permit a finding that Ms. Concordia’s presentation with
    the Board of Directors was a discussion with legal counsel.”          Trial Court
    Opinion, 9/25/14, at 5. It characterized the “apparent purpose of the May
    11, 2011 Board meeting” as one convened to “receive information from a
    high ranking corporate officer, who is not an attorney, in order for the Board
    to fulfill its responsibilities.” 
    Id.
    The court continued, “If the Board was seeking legal advice from
    counsel, counsel would have met privately with Ms. Concordia and
    considered the information received in rendering a legal opinion” and that
    even if “a lawyer for UPMC was present and offered legal advice, a non-
    lawyer’s presentation to the Board of Directors meets none of the
    requirements for an attorney-client relationship.” 
    Id.
     It ordered that UPMC
    divulge all of the materials outlined in interrogatories 23 and 24.
    We first conclude that the attorney-client privilege can apply to a
    meeting of the governing board of an organization with its executive vice-
    president and that the attorney-client privilege potentially applies to the
    information requested in these interrogatories. We also find that a board of
    - 28 -
    J-A04009-15
    J-A04010-15
    directors of a professional health care provider can conduct peer review. We
    remand for UPMC to produce for in camera review the information requested
    in interrogatories 23 and 24 so that it can be determined to what extent
    either asserted privilege applies to any of the requested information.
    The attorney-client privilege is derived from the common law, In re
    Thirty-Third Statewide Investigating Grand Jury, supra, but is also
    codified at 42 Pa.C.S. § 5928, which states: “In a civil matter counsel shall
    not be competent or permitted to testify to confidential communications
    made to him by his client, nor shall the client be compelled to disclose the
    same, unless in either case this privilege is waived upon the trial by the
    client.”   As we observed in In re Thirty-Third Statewide Investigating
    Grand Jury, supra, “The attorney-client privilege is intended to foster
    candid communications between counsel and client, so that counsel may
    provide legal advice based upon the most complete information from the
    client.” Id. at 216. Since the purpose of the attorney-client privilege “is to
    create an atmosphere that will encourage confidence and dialogue between
    attorney and client, the privilege is founded upon a policy extrinsic to the
    protection of the fact-finding process.”      Id. at 216-17.       The actual
    beneficiary of this policy is not only the client but also the justice system,
    which “depends on frank and open client-attorney communication.” Id. at
    217.
    - 29 -
    J-A04009-15
    J-A04010-15
    For a party to invoke the privilege, the following elements must be
    established:
    1) The asserted holder of the privilege is or sought to become
    a client.
    2) The person to whom the communication was made is a
    member of the bar of a court, or his subordinate.
    3) The communication relates to a fact of which the attorney
    was informed by his client, without the presence of strangers, for
    the purpose of securing either an opinion of law, legal services or
    assistance in a legal matter, and not for the purpose of
    committing a crime or tort.
    4) The privilege has been claimed and is not waived by the
    client.
    Red Vision Systems, Inc., 
    supra at 62-63
     (citation omitted). Additionally,
    when “the client is a corporation, the privilege extends to communications
    between its attorney and agents or employees authorized to act on the
    corporation's behalf.” Id. at 60 (citation omitted).
    Initially, we note that UPMC facially invoked this privilege in its
    answers to interrogatories.     While the trial court speculated that Ms.
    Concordia’s presentation was merely to apprise the Board of the situation,
    UPMC indicated the contrary in its answers to the two interrogatories.      It
    asserted that the Board meeting was called in part to review what happened
    and seek legal advice. Although it did not identify the individuals by name,
    UPMC maintained that a lawyer or lawyers were present. Given the gravity
    of the situation and the inevitable filing of a lawsuit by Mr. Yocobet and Ms.
    - 30 -
    J-A04009-15
    J-A04010-15
    Meccanic, it is reasonable and appropriate that the UPMC Board was eliciting
    legal advice from its lawyers.
    We reject the postulation that a corporate entity can obtain legal
    advice only when one of its high-ranking officials meets privately with
    counsel for advice on behalf of the corporation. As we noted in Petrina v.
    Allied Glove Corp., 
    46 A.3d 795
    , 799 (Pa.Super. 2012) (citations omitted;
    emphasis added),
    A corporation is a creature of legal fiction, which can act or
    “speak” only through its officers, directors, or other agents.
    Where a representative for a corporation acts within the scope of
    his or her employment or agency, the representative and the
    corporation are one and the same entity, and the acts performed
    are binding on the corporate principal.
    Thus, the board of directors of a corporation, in addition to its officers, can
    act on its behalf for purposes of application of the attorney-client privilege.
    During the May 11, 2011 Board meeting, Ms. Concordia, a high
    ranking official at UPMC, was discussing the kidney donor program and this
    kidney transplant with its governing board.       Since the meeting may well
    have been called to seek legal advice from the lawyers present, it was
    improper to reject outright the privilege without examination of the factual
    basis for application of the privilege.       The fact that Ms. Concordia was
    communicating by making a presentation is of no consequence since in
    Pennsylvania, “the attorney-client privilege operates in a two-way fashion to
    protect confidential client-to-attorney or attorney-to-client communications
    - 31 -
    J-A04009-15
    J-A04010-15
    made for the purpose of obtaining or providing professional legal advice.”
    Gillard v. AIG Ins. Co., 
    15 A.3d 44
    , 59 (Pa. 2011).
    Additionally, we find that UPMC facially invoked the peer review
    privilege.        As noted earlier, peer review consists of a “procedure for
    evaluation by professional health care providers of the quality and efficiency
    of services ordered or performed by other professional health care
    providers.” 63 P.S. § 425.2. UPMC is a professional health care provider.
    Id. (a professional heath care provider includes “a corporation or other
    organization operating a hospital[.]”). Id.             A review organization includes
    “any hospital board, committee or individual reviewing the professional . . .
    activities of its medical staff[.]” During its May 11, 2011 meeting, the Board
    may have been engaging in peer review.                    UPMC, in its objections to
    interrogatories 23 and 24, made the appropriate proffer as to the
    applicability of the peer review privilege.
    Thus, we conclude that UPMC was improperly ordered to reveal to the
    plaintiffs all of the information sought in the two interrogatories. Rather, in
    camera review7 of the minutes of the meeting, the information disseminated
    ____________________________________________
    7
    The plaintiffs claim that UPMC has refused to submit documents to in
    camera review for purposes of determining whether a privilege prevents
    their dissemination to plaintiffs. Specifically, they assert:
    What is most interesting is that when the Special Master
    indicated that she may review [certain] documents in camera,
    (Footnote Continued Next Page)
    - 32 -
    J-A04009-15
    J-A04010-15
    by Ms. Concordia, and any documents8 submitted to the meeting attendees
    is warranted.
    In T.M. v. Elwyn, Inc., 
    950 A.2d 1050
     (Pa.Super. 2008), Elwyn, the
    appellant, asserted that a broadly-worded discovery order required it to
    reveal documents protected by the attorney-client privilege and the attorney
    work product doctrine and that the discovery order should have provided for
    the exclusion of documents encompassed by either of the two privileges.
    We noted that we could not determine, based upon the record, whether and
    to what extent either privilege applied to the items ruled discoverable in the
    order on appeal, and we reversed the discovery order. Significant herein is
    _______________________
    (Footnote Continued)
    UPMC threatened an immediate appeal. In any event, Plaintiffs
    have a good-faith basis to believe that UPMC's narrative - that
    this was a single isolated event — would be proven patently false
    if UPMC ever has to produce any meaningful discovery
    documents or information.        To date, since UPMC has not
    produced any of the requested documents, Plaintiffs are left with
    nothing but UPMC's narrative and no way to substantively
    challenge the same.
    Appellees’ brief at 15 (appeal No. 1230 WDA 2014).
    T.M. v. Elwyn, Inc., 
    950 A.2d 1050
     (Pa.Super. 2008), as discussed in
    the text, provides that in camera review is to be undertaken if such review is
    needed to determine if a privilege is applicable to an item requested in
    discovery. We remind UPMC that the case law mandates in camera review,
    in appropriate circumstances, of items in a privilege log.
    8
    We refer to our discussion in the body of the text supra as to the types of
    documents that have confidentiality for purposes of the Act. Documents
    submitted at the May 11, 2011 Board meeting would not automatically be
    privileged simply due to their submission to a peer review process.
    - 33 -
    J-A04009-15
    J-A04010-15
    the fact that we concluded that Elwyn had to create a privilege log and that
    the trial court had to issue a ruling as to the discoverability of each
    document placed in the log and sought by the opposing party.
    We reminded Elwyn that, “as the party invoking these privileges, it
    must initially set forth facts showing that the privilege has been properly
    invoked” before the burden shifted to the party asking for disclosure “to set
    forth facts showing that disclosure will not violate the attorney-client
    privilege, e.g., because the privilege has been waived or because some
    exception applies.” Id. at 1063 (citation and quotation marks omitted). We
    continued that if, “upon remand, Elwyn is able to identify certain materials
    encompassed in the discovery request that are subject to the attorney-client
    privilege or work product doctrine, then the trial court will be able to assess
    whether those materials are discoverable.”      Id.   We remanded with the
    notation that “the court may conduct in camera review of documents
    identified by Elwyn to be subject to a privilege, to better analyze the
    privilege issues, as needed.” Id.; see also Gocial v. Independence Blue
    Cross, 
    827 A.2d 1216
    , 1223 (Pa.Super. 2003) (trial court improperly
    required disclosure of all materials contained in a privilege log; trial court
    had to “rule on the relevance of each item or explain why the privileges
    raised were inapplicable;” in “some instances, in camera review may be
    required”).
    - 34 -
    J-A04009-15
    J-A04010-15
    As it applies to the present case, T.M. provides that, since UPMC
    raised the appropriate allegations that the attorney-client privilege and/or
    peer review privilege potentially applied, the trial court could not require
    disclosure without examining the requested documents in camera to
    determine        whether   and   to   what   extent   the   privileges   applied   to
    interrogatories numbered 23 and 24. We direct the creation of a privilege
    log, as mandated by T.M. and any documents identified on said log must be
    reviewed in camera by either the trial court or the master to determine
    whether those materials are discoverable.         Thus, at appeal number 1230
    WDA 2014, the June 26, 2014 order is reversed and the matter is remanded
    for proceedings consistent with this decision.
    At 569 WDA 2014, the March 11, 2014 order is affirmed.               At 1230
    WDA 2014, the June 26, 2014 order is reversed.                    Case remanded.
    Jurisdiction relinquished.
    Judge Olson joins the opinion.
    Judge Strassburger files a concurring and dissenting opinion.
    Judgment Entered.
    Joseph D. Seletyn, Esq.
    Prothonotary
    Date: 6/5/2015
    - 35 -
    J-A04009-15
    J-A04010-15
    - 36 -